Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
Louis M KwongDepartment of Orthopedic Surgery, Harbor-UCLA Medical Center, Torrance, CA, USAAbstract: Routine thromboprophylaxis represents the current standard of care in the management of patients following total hip or knee replacement. Legacy agents used to address the issue of risk of venous th...
Saved in:
Main Author: | Kwong LM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/9a6b65f9b54544fba836e20c1e33317a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Venous thromboembolism in patients hospitalized for knee joint replacement surgery
by: Karsten Keller, et al.
Published: (2020) -
Rivaroxaban in acute venous thromboembolism: UK prescribing experience
by: Victoria Speed, et al.
Published: (2021) -
Efficacy and safety of antithrombotic therapy with non-vitamin K antagonist oral anticoagulants after transcatheter aortic valve replacement: a systematic review and meta-analysis
by: Qing An, et al.
Published: (2021) -
Design and Baseline Data for a Prospective Observational Study of Rivaroxaban in Patients with Venous Thromboembolism in Japan (XASSENT)
by: Ikuo Fukuda, et al.
Published: (2021) -
Management of Venous Thromboembolism in Children: Current Recommendations and Therapeutic Options
by: Bosch A, et al.
Published: (2020)